Thank you Trding (and ohm from previous research articles)! I've been filing them and will come back and read further if/when CytoDyn announces they are pursuing these indications. Currently, I'm only forecasting potential valuation for approved P2+ indications......but I now have articles saved of 14 completely different indications linked to CCR5 (includes current P2+ trials).